NeuroSync
PrivateLast Round
Seed
Mar 11, 2019
Total Funding Raised
$4.13M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
NeuroSync is a neurotechnology company that provides a cloud-based analytics platform for assessing abnormal eye movements to aid in the diagnosis and treatment of various neurological conditions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, AR/VR Hardware, Sports & Fitness
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroSync Comparables
Compare NeuroSync with similar companies based on industry and business-model similarity.
NeuroSync Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 11, 2019 | ||||
| Series A Extension | Jan 3, 2018 | ||||
| Seed | Sep 7, 2017 | ||||
| Grant | Jun 13, 2017 | ||||
| Accelerator | Apr 4, 2017 |
NeuroSync Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Quadrant Management | Series A Extension |
| MassChallenge Israel | Grant, Accelerator |
| StartUp Health | Seed |
| Quartus Capital Partners | Growth Equity |
| Oceanic Partners | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Grew 49% QoQ, from 35 to 52 employees.
- Jul 25, 2026
Monthly visitors increased 112% MoM to 5.3K.
Recent news
Latest coverage and updates
- recognized_asSep 18, 2026
NeuroSync Inc. will be recognized as 1st Runner-Up at GEF 2024 on Nov 8th '26.
NeuroSync Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NeuroSync's valuation, stock price, and market status.
Is NeuroSync a public or private company?
NeuroSync is a private company.
What is the current stock price of NeuroSync?
NeuroSync is a private company with no public stock price. No recent secondary market data is available.
How much is NeuroSync worth (valuation)?
Valuation information for NeuroSync is not publicly available.
Can I buy NeuroSync stock?
NeuroSync shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was NeuroSync's last funding round?
NeuroSync's most recent funding round was Seed on March 11, 2019.
Who are the main investors in NeuroSync?
Key investors in NeuroSync include Quadrant Management, StartUp Health, Quartus Capital Partners.
Will NeuroSync IPO soon?
No public IPO plans have been announced for NeuroSync.
How can I track NeuroSync secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NeuroSync's secondary market activity and sign up for updates.